Published on 23/12/2025
How to Select the Most Suitable Wearables for Your Clinical Study
Why Wearable Device Selection is Critical in Trial Design
Selecting the right wearable devices for a clinical trial is more than a procurement decision—it’s a regulatory, operational, and scientific one. Each study’s endpoints, population, duration, and geographic scope influence the choice of wearable technology. Devices that are not fit-for-purpose can lead to poor compliance, low data quality, and regulatory rejections.
For example, using a wrist-based optical sensor to measure blood oxygen saturation (SpO2) may not yield accurate results in elderly or cardiac patients, where peripheral perfusion is low. This could compromise endpoint validity. Regulatory authorities like the FDA and EMA expect sponsors to justify their choice of wearable, supported by validation and performance data.
According to a review published by PharmaGMP, nearly 35% of wearable-related protocol deviations in decentralized trials stem from misalignment between device capabilities and endpoint requirements.
Key Criteria for Evaluating Wearable Devices
Sponsors should evaluate wearable options based on both scientific and operational parameters. The following criteria are commonly used:
- Endpoint Alignment: Is the device validated to measure the required primary or secondary endpoint?
- Population Suitability: Is the device ergonomic and usable for the study population (e.g., pediatric, geriatric)?
- Data Integrity: Does the device maintain ALCOA+ standards?
- Battery Life and Storage: Can it operate uninterrupted for at least 24-72 hours?
- Connectivity: Can it sync with mobile devices or Wi-Fi for real-time data upload?
- Regulatory Status: Has the device received 510(k), CE mark, or local regulatory clearance?
The following dummy table illustrates how wearable devices can be scored across critical attributes:
| Device | Validated Endpoint | Battery Life | Data Accuracy | Regulatory Status | Suitability Score |
|---|---|---|---|---|---|
| CardioPatch X | ECG, HR | 72 hrs | 98% | FDA 510(k) | 9/10 |
| SleepTrack V2 | Sleep Staging | 48 hrs | 91% | CE Mark | 8/10 |
| BioBand Mini | Steps, HR | 24 hrs | 87% | None | 6/10 |
Study-Specific Factors Influencing Wearable Choice
No single wearable is suitable for all studies. Several variables must be considered during feasibility assessment:
- Study Duration: Long-term studies need durable devices with strong battery life and user support mechanisms.
- Decentralized vs On-Site: Remote trials require more autonomous wearable devices with self-sync capabilities.
- Geography: Device connectivity and regulatory approvals vary by country.
- Site Support Capacity: If sites lack IT support, avoid complex setups requiring firmware updates.
A cardiovascular trial conducted across 12 countries faced sync issues in rural regions due to lack of 4G connectivity. Switching to a wearable with offline storage and delayed sync capability resolved 80% of data gaps, as shared by ClinicalStudies.in.
Vendor Qualification and Technical Due Diligence
Selecting the right wearable involves more than product specs—it requires vendor evaluation. Sponsors should audit the wearable vendor’s:
- Software Development Lifecycle (SDLC)
- Data Privacy and Security Framework (e.g., GDPR, HIPAA)
- Technical Support SLAs and Uptime Guarantees
- Firmware Version Control and Update Policies
- Integration Capabilities with EDC or CTMS systems
Conduct a vendor qualification questionnaire and request validation packages, including performance testing, calibration protocols, and historical deviations.
Also ensure the vendor provides APIs with thorough documentation. This is crucial if integration with sponsor data platforms is required. Sponsors may also request a sandbox environment to test integrations during feasibility.
Developing a Wearable Selection SOP
Standardizing the wearable selection process improves consistency across studies and enhances audit readiness. An internal SOP for wearable evaluation should include:
- Device feasibility checklist and scoring criteria
- Cross-functional review process (clinops, IT, regulatory, QA)
- Fit-for-purpose justification template
- Vendor audit and qualification checklist
- Documentation for change control in device selection
For example, in a CNS trial involving elderly patients, a sponsor used a wearable with minimal screen glare and tactile buttons after SOP-driven usability testing. This improved compliance by 22% over the first 30 days.
Best Practices for Operational Deployment of Selected Devices
Once a device is selected, implementation planning begins. The following practices help ensure smooth deployment:
- Provide trial-specific user manuals with annotated screenshots
- Include device usage training during SIV and site startup
- Set up a central tech support line (with regional escalation)
- Prepare backup devices at each site or with courier access
- Monitor device compliance and sync rates weekly
Include wearable deployment KPIs in your clinical quality dashboard. For decentralized trials, consider remote device monitoring capabilities to check signal strength, battery level, and sync status.
According to ICH E6(R3), centralized monitoring and real-time data oversight are key components of modern risk-based quality management systems.
Conclusion: Strategic Selection for Better Outcomes
Choosing the right wearable device is a foundational step toward a successful, compliant, and efficient clinical trial. It requires aligning study needs with technical capabilities, regulatory expectations, and patient usability. A structured, SOP-driven selection and deployment process ensures wearables enhance—rather than complicate—your study.
As wearable technology evolves, proactive vendor engagement, robust testing, and real-world feedback loops will remain essential for pharma and CRO professionals aiming to run trials at the intersection of science and innovation.